Home › Funds › SEIZERT CAPITAL PARTNERS, LLC › ELV

SEIZERT CAPITAL PARTNERS, LLC position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

SEIZERT CAPITAL PARTNERS, LLC reported holding 111,954 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$43.5M, representing 1.89% of its reported portfolio and ranking #26 among its reported holdings. SEIZERT CAPITAL PARTNERS, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)111.95K sh
Reported value held$43.53M
Portfolio Weight1.89%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SEIZERT CAPITAL PARTNERS, LLC's ELV position evolved

SEIZERT CAPITAL PARTNERS, LLC first disclosed a stake in ELV in Q3 2023 at 86,075 shares (US$37.5M). The position peaked in Q1 2025 at 133,776 shares, worth US$58.2M. Across 13 filings, SEIZERT CAPITAL PARTNERS, LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 111,954 shares valued at US$43.5M — a reduction of -8,988 shares quarter over quarter.. Notable position changes include a 26% increase in Q3 2024 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 86.08K $37.48M New
Q4 2023 85.93K $40.52M Hold
Q1 2024 87.15K $45.19M Add
Q2 2024 82.52K $44.71M Reduce
Q3 2024 104.23K $54.20M Add
Q4 2024 130.26K $48.05M Add
Q1 2025 133.78K $58.19M Add
Q2 2025 133.85K $52.06M Hold
Q3 2025 127.83K $41.30M Reduce
Q4 2025 125.93K $44.15M Reduce
Q1 2026 120.84K $35.38M Reduce
Q2 2026 120.94K $46.77M Hold
Q3 2026 111.95K $43.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has SEIZERT CAPITAL PARTNERS, LLC held ELV?

SEIZERT CAPITAL PARTNERS, LLC has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SEIZERT CAPITAL PARTNERS, LLC's current position in ELV?

As of Q3 2026, SEIZERT CAPITAL PARTNERS, LLC holds 111.95K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $43.53M, representing 1.89% of its reported portfolio and ranking #26.

Has SEIZERT CAPITAL PARTNERS, LLC been buying or selling ELV?

In the latest 13F filing (Q3 2026), SEIZERT CAPITAL PARTNERS, LLC reduced its position in ELV. The position peaked in Q1 2025 at 133.78K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.